Bausch Health Co. Inc. (NYSE: BHC) reported Q1 revenue of $2.01 billion versus the consensus estimate of $2.04 billion.

• GAAP Net Loss of $152 Million
• Adjusted EBITDA (non-GAAP)1 of $813 Million

2020 Financial Outlook

Bausch Health lowered its revenue and Adjusted EBITDA (non-GAAP) guidance ranges for the full year of 2020, primarily due to the actual and anticipated impacts of the COVID-19 pandemic:

• Lowered full-year revenue range from $8.65 – $8.85 billion to $7.80 – $8.20 billion
• Lowered full-year Adjusted EBITDA (non-GAAP) range from $3.50 – $3.65 billion to $3.15 – $3.35 billion

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.